These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11587187)

  • 1. Improved preparation of amyloid-beta peptides using DBU as Nalpha-Fmoc deprotection reagent.
    Tickler AK; Barrow CJ; Wade JD
    J Pept Sci; 2001 Sep; 7(9):488-94. PubMed ID: 11587187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aspartimide problem in Fmoc-based SPPS. Part II.
    Mergler M; Dick F; Sax B; Stähelin C; Vorherr T
    J Pept Sci; 2003 Aug; 9(8):518-26. PubMed ID: 12952393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide thioester preparation by Fmoc solid phase peptide synthesis for use in native chemical ligation.
    Clippingdale AB; Barrow CJ; Wade JD
    J Pept Sci; 2000 May; 6(5):225-34. PubMed ID: 10823491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized preparation of deca(L-alanyl)-L-valinamide by 9-fluorenylmethyloxycarbonyl (Fmoc) solid-phase synthesis on polyethylene glycol-polystyrene (PEG-PS) graft supports, with 1,8-diazobicyclo [5.4.0]-undec-7-ene (DBU) deprotection.
    Kates SA; Solé NA; Beyermann M; Barany G; Albericio F
    Pept Res; 1996; 9(3):106-13. PubMed ID: 8875589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problem of aspartimide formation in Fmoc-based solid-phase peptide synthesis using Dmab group to protect side chain of aspartic acid.
    Ruczyński J; Lewandowska B; Mucha P; Rekowski P
    J Pept Sci; 2008 Mar; 14(3):335-41. PubMed ID: 17975850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient access to highly pure β-amyloid peptide by optimized solid-phase synthesis.
    Choi JW; Kim HY; Jeon M; Kim DJ; Kim Y
    Amyloid; 2012 Sep; 19(3):133-7. PubMed ID: 22799493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aspartimide problem in Fmoc-based SPPS. Part III.
    Mergler M; Dick F
    J Pept Sci; 2005 Oct; 11(10):650-7. PubMed ID: 15849777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limiting racemization and aspartimide formation in microwave-enhanced Fmoc solid phase peptide synthesis.
    Palasek SA; Cox ZJ; Collins JM
    J Pept Sci; 2007 Mar; 13(3):143-8. PubMed ID: 17121420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing aspartimide formation in Fmoc SPPS of Asp-Gly containing peptides--practical aspects of new trialkylcarbinol based protecting groups.
    Behrendt R; Huber S; White P
    J Pept Sci; 2016 Feb; 22(2):92-7. PubMed ID: 26751703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine?
    Luna OF; Gomez J; Cárdenas C; Albericio F; Marshall SH; Guzmán F
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27854291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microwave-assisted solid-phase peptide synthesis based on the Fmoc protecting group strategy (CEM).
    Vanier GS
    Methods Mol Biol; 2013; 1047():235-49. PubMed ID: 23943491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edman degradation sequence analysis of resin-bound peptides synthesized by 9-fluorenylmethoxycarbonyl chemistry.
    Fields CG; VanDrisse VL; Fields GB
    Pept Res; 1993; 6(1):39-47. PubMed ID: 8439735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aspartimide problem in Fmoc-based SPPS. Part I.
    Mergler M; Dick F; Sax B; Weiler P; Vorherr T
    J Pept Sci; 2003 Jan; 9(1):36-46. PubMed ID: 12587881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New t-butyl based aspartate protecting groups preventing aspartimide formation in Fmoc SPPS.
    Behrendt R; Huber S; Martí R; White P
    J Pept Sci; 2015 Aug; 21(8):680-7. PubMed ID: 26077723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of glyoxylyl peptides using an Fmoc-protected alpha,alpha'-diaminoacetic acid derivative.
    Far S; Melnyk O
    J Pept Sci; 2005 Jul; 11(7):424-30. PubMed ID: 15641117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-Phase synthesis of a dendritic peptide related to a retinoblastoma protein fragment utilizing a combined boc- and fmoc-chemistry approach.
    Cavallaro V; Thompson P; Hearn M
    J Pept Sci; 2001 May; 7(5):262-9. PubMed ID: 11428547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete TFA deprotection of N-terminal trityl-asparagine residue in fmoc solid-phase peptide chemistry.
    Friede M; Denery S; Neimark J; Kieffer S; Gausepohl H; Briand JP
    Pept Res; 1992; 5(3):145-7. PubMed ID: 1421802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete Fmoc deprotection in solid-phase synthesis of peptides.
    Larsen BD; Holm A
    Int J Pept Protein Res; 1994 Jan; 43(1):1-9. PubMed ID: 8138344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nsc and Fmoc Nalpha-amino protection for solid-phase peptide synthesis: a parallel study.
    Carreño C; Méndez ME; Kim YD; Kim HJ; Kates SA; Andreu D; Albericio F
    J Pept Res; 2000 Aug; 56(2):63-9. PubMed ID: 10961540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DBU as an N alpha-deprotecting reagent for the fluorenylmethoxycarbonyl group in continuous flow solid-phase peptide synthesis.
    Wade JD; Bedford J; Sheppard RC; Tregear GW
    Pept Res; 1991; 4(3):194-9. PubMed ID: 1823190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.